Ghana

Africa’s first Lassa fever vaccine clinical trial begins in Ghana

INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today announced the first participant was dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever, in Ghana. The Phase 1B clinical trial (LSV-002), ongoing at the Noguchi Memorial Institute for Medical Research in Accra, Ghana, is the first vaccine clinical trial for Lassa Fever to be conducted in West

Ghana, Ivory Coast get COVI-19 vaccine ahead of Nigeria

As government officials in Nigeria continue to promise citizens that doses of COVID-19 vaccines will soon become available in the country, Ghana has become the first to receive COVID-19 vaccine on the continent through the Gavi and WHO-led COVAX platform. The vaccines arrived on a flight from Mumbai, via Dubai, where the flight also collected a shipment of syringes from a Gavi-funded stockpile at UNICEF’s regional Supply Hub. In a statement, COVAX today announced that 600,000 doses of the AstraZeneca/Oxford vaccine